Betül Çiğdem Yortanlı

Dr. Betül Çiğdem Yortanlı

Department of Internal Medicine, University of Health Sciences, Konya City Hospital, Konya, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KKKorhan Kollu
Korhan Kollu
Betül Çiğdem YortanlıBetül Çiğdem Yortanlı
Betül Çiğdem Yortanlı
AÇAYŞE NUR ÇİÇEK
AYŞE NUR ÇİÇEK
ESEmre Susam
Emre Susam
NKNalan Karakas
Nalan Karakas
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
Background: This study aimed to evaluate the prognostic value of some novel laboratory indices in intensive care unit (ICU)-hospitalized sepsis patients. Methods: This retrospective, observational study included 400 patients with sepsis. The indices studied were the C-reactive protein/albumin ratio (CAR), hemoglobin, albumin lymphocyte, and platelet (HALP) score, lymphocyte/monocyte ratio (LMR), prognostic nutritional index (PNI), systemic immune inflammatory index (SII), vitamin B12xC-reactive protein index (BCI), systemic inflammatory response index (SIRI), and platelet/lymphocyte ratio (PLR). The predicting effects of these indices in ICU mortality, along with other clinical outcomes, were investigated. Results: The median age of the study population was 73 (18–95) years and 51.6% were males. The ICU mortality rate was 51.7%. Deceased patients with sepsis had an increased age and high APACHE II and SOFA scores compared to the survivors (p < 0.05 for all). In the multivariate logistic regression analysis, age (HR = 1.069, p = 0.038 in Model 1 vs. HR = 1.053, p = 0.001 in Model 2), SOFA score (HR = 2.145, p < 0.001 in Model 1 vs. HR = 1.740, p < 0.001 in Model 2), phosphorus levels (in Model 1, HR = 0.608, p = 0.037), and CAR (in Model 2, HR = 1.012, p = 0.023) were independent associated factors for ICU mortality. According to the ROC analyses, the SOFA (AUC = 0.879, p < 0.001) and APACHE II (AUC = 0.769, p < 0.001) scores showed high accuracy in predicting ICU mortality, while the PNI (AUC = 0.675, p < 0.001), CAR (AUC = 0.609, p < 0.001), and the BCI (AUC = 0.648, p < 0.001) showed limited accuracy. However, the HALP score did not reach a significant level in predicting ICU mortality (p = 0.067). Conclusions: Excluding the HALP score, the new laboratory indices mentioned above may be prognostic markers for predicting clinical outcomes in intensive care units for patients with sepsis. However, these indices need to be supported by larger patient populations.

19 June 2025 in Journal of Investigative Medicine
Verified
Journal Article
Closed access
Betül Çiğdem YortanlıBetül Çiğdem Yortanlı
Betül Çiğdem Yortanlı
ÜCÜmmügülsüm Can
Ümmügülsüm Can
Mehmet YortanlıMehmet Yortanlı
Mehmet Yortanlı
KKKorhan Kollu
Korhan Kollu
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
Graves’ disease (GD) is an autoimmune thyroid disorder characterized by excessive thyroid hormone production driven by thyroid-stimulating hormone (TSH) receptor antibodies (TRAb). This study aimed to investigate the relationship between serum spexin (SPX) levels, TRAb levels, thyroid ultrasound findings, and metabolic parameters in GD patients while evaluating SPX as a potential biomarker for autoimmune inflammation. A prospective, single-center study included 45 GD patients and 45 healthy controls. Serum TSH, free T3, free T4, anti-thyroglobulin, antithyroid peroxidase, TRAb, and SPX levels were measured. Thyroid ultrasonography classified patients into mild, moderate, and high heterogeneity groups. SPX levels were significantly higher in GD patients compared to controls (p < 0.001) and showed a strong positive correlation with TRAb levels (r = 0.579, p < 0.001) and thyroid heterogeneity (p < 0.001). Newly diagnosed patients (<6 months) exhibited the highest SPX levels, which decreased with prolonged disease duration. Receiver operating characteristic analysis identified a cutoff value of 105 pg/mL for SPX, yielding 60% sensitivity and 91.1% specificity (area under the curve: 0.765, p < 0.001). SPX levels were also inversely correlated with disease duration and positively associated with inflammatory markers, suggesting its utility in monitoring disease activity and progression. These findings highlight SPX as a novel biomarker for assessing disease severity and autoimmune inflammation in GD. Incorporating SPX measurements into clinical practice may aid in early diagnosis, disease stratification, and therapeutic monitoring, ultimately improving personalized care for GD patients.

12 September 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BBBensu Bulut
Bensu Bulut
MÖMedine Akkan Öz
Medine Akkan Öz
MGMurat Genç
Murat Genç
AGAyşenur Gür
Ayşenur Gür
Mehmet YortanlıMehmet Yortanlı
Mehmet Yortanlı
ZUZekeriya Uykan
Zekeriya Uykan
Background: This study evaluates the diagnostic performance of three multimodal large language models (LLMs)—ChatGPT-4o, Gemini 2.0, and Claude 3.5—in identifying pneumothorax from chest radiographs. Methods: In this retrospective analysis, 172 pneumothorax cases (148 patients aged >12 years, 24 patients aged ≤12 years) with both chest radiographs and confirmatory thoracic CT were included from a tertiary emergency department. Patients were categorized by age and pneumothorax size (small/large). Each radiograph was presented to all three LLMs accompanied by basic symptoms (dyspnea or chest pain), with each model analyzing each image three times. Diagnostic accuracy was evaluated using overall accuracy (all three responses correct), strict accuracy (≥2 responses correct), and ideal accuracy (≥1 response correct), alongside response consistency assessment using Fleiss’ Kappa. Results: In patients older than 12 years, ChatGPT-4o demonstrated the highest overall accuracy (69.6%), followed by Claude 3.5 (64.9%) and Gemini 2.0 (57.4%). Performance was significantly poorer in pediatric patients across all models (20.8%, 12.5%, and 20.8%, respectively). For large pneumothorax in adults, ChatGPT-4o showed significantly higher accuracy compared to small pneumothorax (81.6% vs. 42.2%; p < 0.001). Regarding consistency, Gemini 2.0 demonstrated excellent reliability for large pneumothorax (Kappa = 1.00), while Claude 3.5 showed moderate consistency across both pneumothorax sizes. Conclusion: This study, the first to evaluate these three current multimodal LLMs in pneumothorax identification across different age groups, demonstrates promising results for potential clinical applications, particularly for adult patients with large pneumothorax. However, performance limitations in pediatric cases and with small pneumothoraces highlight the need for further validation before clinical implementation.

1 January 2023 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
MEM. Ali̇ Eryilmaz
M. Ali̇ Eryilmaz
Betül Çiğdem YortanlıBetül Çiğdem Yortanlı
Betül Çiğdem Yortanlı
IÜİlKnur Rahi̇mE Ünal
İlKnur Rahi̇mE Ünal
BÜBariş Can Ünal
Bariş Can Ünal
NANergi̇s Aksoy
Nergi̇s Aksoy
Background/aim: To investigate the possible relationship between pectoralis muscle (PM) measurement and frailty in older women with breast cancer (BC) (preoperatively defined as stage 1, 2, and 3 diseases). Materials and methods: This retrospective, observational study was conducted at Konya Training and Research Hospital between June and December 2020. A total of 102 patients [median age 62.5 years, median follow-up period two years] were included in the study. PM measurements were obtained from thorax computerized tomography (CT). Pectoralis muscle index (PMI) was calculated by dividing the PM area by the height square of the patients (cm2/m2). Pectoralis muscle density (PMD) was evaluated using CT findings, including their Hounsfield Units (HU). Frailty status and sarcopenia-risk assessments were done by a telephone interview in September 2020 using the FRAIL index (categorized as robust or nonrobust) and SARC-F questionnaire (classified as no sarcopenia-risk or risk of sarcopenia), respectively. PM measurements were compared between robust and nonrobust patients and between patients with a risk of sarcopenia and no sarcopenia risk. Results: The nonrobust patients had lower pectoralis major muscle index (PMaMI) (p = 0.041) and pectoralis major muscle density (PMaD) (p = 0.020) levels than robust patients in the whole study sample. PMI (p = 0.017) and PMaMI (p = 0.010) levels were significantly lower in the nonrobust patients than in robust patients with early-stage BC. Frailty status was positively correlated with age (rho: 0.621; p < 0.001), BC stage (rho: 0.220; p = 0.026), and SARC-F score (rho: 0.747; p < 0.001), and negatively correlated with PMaMI (rho: -0.197; p = 0.047) and PMaD (rho: -0.237; p = 0.016). There were significant associations between PMaMI (OR: 0.467, 95% Confidence Interval (CI): 0.226-0.962 p = 0.039) and PMI (OR: 0.543, 95% CI: 0.299-0.986 p = 0.045) levels with frailty status (being nonrobust) in regression models. Conclusion: In the study, it has been shown that pectoralis muscle assessment might be a related parameter to frailty in older women with breast cancer.

27 January 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
Betül Çiğdem YortanlıBetül Çiğdem Yortanlı
Betül Çiğdem Yortanlı
KKKorhan Kollu
Korhan Kollu
AVAhmet Sami Varol
Ahmet Sami Varol
Mehmet YortanlıMehmet Yortanlı
Mehmet Yortanlı
ESEkrem Taha Sert
Ekrem Taha Sert
Lactate clearance (LC) has emerged as a potential prognostic marker in critically ill patients. However, its role in predicting massive transfusion (MT) re

30 May 2025 in Medicine
Verified
Journal Article
Open access
SÇSelma Özlem Çelikdelen
Selma Özlem Çelikdelen
ÜCÜmmügülsüm Can
Ümmügülsüm Can
HYHasan Basri Yildirim
Hasan Basri Yildirim
Betül Çiğdem YortanlıBetül Çiğdem Yortanlı
Betül Çiğdem Yortanlı
ZTZeynep İcLal Turgut
Zeynep İcLal Turgut
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
This study investigated the association between hepassocin levels (HL) and microalbuminuria in patients with type 2 diabetes mellitus. This cross-sectional study included 85 patients with diabetes (for at least 5 years) patients aged 18 to 75 years. Among the patients, 44 were diagnosed with stage 3 diabetic nephropathy (case group, spot urine microalbumin: 30–300 mg/day), while 41 had no diabetic nephropathy (control group; spot urine microalbumin < 30 mg/day). Patients general characteristics and comorbidities were recorded. Blood samples were collected from the patients to measure HL using the ELISA method. Additionally, various biochemical and hormonal laboratory parameters were analyzed. The assessments included hemogram, fasting blood glucose, HbA1c, blood urea nitrogen, creatinine, estimated glomerular filtration rate, uric acid, calcium, phosphorus, albumin, aspartate aminotransferase, alanine aminotransferase, sodium, potassium, and lipid profile. The HLs of the case and control groups were compared. Additionally, all patients were divided into quartiles based on their HLs, and further statistical analyses were performed. The median age of the patients was 60 years (range: 29–73), and 50 were women (58.8%). The median body mass index was 32.46 kg/m², HbA1c was 8%, and glomerular filtration rate was 94 mL/min. Median serum HLs were recorded at 0.31 ng/mL (range: 0.28–10.81). The median serum HL of the case and control groups was similar (0.31 vs 0.31 ng/mL, P = .595). In the analyses stratifying patients into quartiles based on their HL, the Q4 group (the group with the highest HL) exhibited significantly higher microalbuminuria rates compared to the other groups (Q1 65 %, Q2 35%, Q3 41.4%, Q4 75.0%, P = .039). The rates of patients using dipeptidyl peptidase 4 inhibitors were observed to be higher in the Q1 group (the group with the lowest HL) than in other groups (Q1 80%, Q2 50%, Q3 37.9%, Q4 50.0%, P = .035). This study showed that HL might be associated with high microalbuminuria levels in patients with type 2 diabetes mellitus. Additionally, using dipeptidyl peptidase 4 inhibitor therapy might be associated with lower HL. However, prospectively designed studies are needed to elucidate more accurate findings about the issue as noted above.